Family Office Briefing on research byNewmark·Apr 24, 2026
Boston Life Sciences Market Report 1Q26
Boston life sciences market shows signs of stabilization in 1Q26 — family offices should consider co-GP opportunities with established operators.
Key Metrics
| Metric | Value |
|---|---|
| Net Absorption | negative |
| Leasing Velocity | strongest since 3Q22 |
| Asking Rents | sliding |
Metrics extracted from the source report and independently fact-checked. Method →
Full report
Newmark
Building a thesis around Boston? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.